<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35891466</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>07</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>The Self-Reported Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) and PainDETECT Questionnaires in COVID-19 Survivors with Post-COVID Pain.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1486</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v14071486</ELocationID><Abstract><AbstractText>This study aimed to analyze correlations between Self-Report Leeds Assessment of Neuropathic Symptoms (S-LANSS) and PainDETECT with proxies of sensitization, pain-related, or psychological/cognitive variables in coronavirus disease, 2019 (COVID-19) survivors exhibiting post-COVID pain. Demographic, clinical, psychological, cognitive, sensitization-associated symptoms, and health-related quality of life were collected in 146 survivors with post-COVID pain. The PainDETECT and S-LANSS questionnaires were used for assessing neuropathic pain-related symptoms. Patients were assessed with a mean of 18.8 (SD 1.8) months after hospitalization. Both questionnaires were positively associated with pain intensity (p &lt; 0.05), anxiety (PainDETECT p &lt; 0.05; S-LANSS p &lt; 0.01), sensitization-associated symptoms (p &lt; 0.01), catastrophism (p &lt; 0.01), and kinesiophobia (p &lt; 0.01) and negatively associated with quality of life (PainDETECT p &lt; 0.05; S-LANSS p &lt; 0.01). Depressive levels were associated with S-LANSS (p &lt; 0.05) but not with PainDETECT. The stepwise regression analyses revealed that 47.2% of S-LANSS was explained by PainDETECT (44.6%), post-COVID pain symptoms duration (1.7%), and weight (1.1%), whereas 51.2% of PainDETECT was explained by S-LANSS (44.6%), sensitization-associated symptoms (5.4%), and anxiety levels (1.2%). A good convergent association between S-LANSS and PainDETECT was found. Additionally, S-LANSS was associated with symptom duration and weight whereas PainDETECT was associated with sensitization-associated symptoms and anxiety levels, suggesting that the two questionnaires evaluate different aspects of the neuropathic pain spectrum in post-COVID pain patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-de-Las-Pe&#xf1;as</LastName><ForeName>C&#xe9;sar</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3772-9690</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Universidad Rey Juan Carlos, Alcorc&#xf3;n, 28922 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Neuroplasticity and Pain (CNAP), SMI, Department of Health Science and Technology, Faculty of Medicine, Aalborg University, DK-9220 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valera-Calero</LastName><ForeName>Juan Antonio</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0002-3379-8392</Identifier><AffiliationInfo><Affiliation>Department of Physiotherapy, Faculty of Health, Universidad Camilo Jos&#xe9; Cela, 28692 Villanueva de la Ca&#xf1;ada, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VALTRADOFI Research Group, Department of Physiotherapy, Faculty of Health, Camilo Jose Cela University, 28692 Villanueva de la Ca&#xf1;ada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrero-Montes</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5732-8344</Identifier><AffiliationInfo><Affiliation>Departamento de Enfermer&#xed;a, Universidad de Cantabria, 39008 Santander, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n en Enfermer&#xed;a, Instituto de Investigaci&#xf3;n Sanitaria Valdecilla (IDIVAL), 39011 Santander, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del-Valle-Loarte</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-0748-2594</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Hospital Universitario Severo Ochoa, 28911 Leganes, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Rosado</LastName><ForeName>Rafael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Hospital Universitario Severo Ochoa, 28911 Leganes, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrer-Pargada</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Servicio de Neumolog&#xed;a, Hospital Universitario Marqu&#xe9;s de Valdecilla, 39008 Santander, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arendt-Nielsen</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Neuroplasticity and Pain (CNAP), SMI, Department of Health Science and Technology, Faculty of Medicine, Aalborg University, DK-9220 Aalborg, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Gastroenterology, Mech-Sense, Aalborg University Hospital, DK-9000 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Par&#xe1;s-Bravo</LastName><ForeName>Paula</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-7745-3006</Identifier><AffiliationInfo><Affiliation>Departamento de Enfermer&#xed;a, Universidad de Cantabria, 39008 Santander, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n en Enfermer&#xed;a, Instituto de Investigaci&#xf3;n Sanitaria Valdecilla (IDIVAL), 39011 Santander, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009437" MajorTopicYN="Y">Neuralgia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">PainDETECT</Keyword><Keyword MajorTopicYN="N">S-LANSS</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">neuropathic</Keyword><Keyword MajorTopicYN="N">pain</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>27</Day><Hour>1</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35891466</ArticleId><ArticleId IdType="pmc">PMC9324682</ArticleId><ArticleId IdType="doi">10.3390/v14071486</ArticleId><ArticleId IdType="pii">v14071486</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Florencio L.L., Cuadrado M.L., Plaza-Manzano G., Navarro-Santana M. Prevalence of Post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur. J. Int. Med. 2021;92:55&#x2013;70. doi: 10.1016/j.ejim.2021.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Navarro-Santana M., Plaza-Manzano G., Palacios-Ce&#xf1;a Arendt-Nielsen L. Time course prevalence of Post-COVID pain symptoms of musculoskeletal origin in patients who had survived to SARS-CoV-2 infection: A systematic review and meta-analysis. Pain. 2022;163:1220&#x2013;1231. doi: 10.1097/j.pain.0000000000002496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002496</ArticleId><ArticleId IdType="pubmed">34561390</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., de-la-Llave-Rinc&#xf3;n A.I., Ortega-Santiago R., Ambite-Quesada S., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Arias-Naval&#xf3;n J.A., Hern&#xe1;ndez-Barrera V., Mart&#xed;n-Guerrero J.D., Pellicer-Valero O.J., et al. Prevalence and risk factors of musculoskeletal pain symptoms as long-term post-COVID sequelae in hospitalized COVID-19 survivors: A multicenter study. Pain. 2021 doi: 10.1097/j.pain.0000000000002564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002564</ArticleId><ArticleId IdType="pubmed">34913880</ArticleId></ArticleIdList></Reference><Reference><Citation>Attal N., Martinez V., Bouhassira D. Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic. Pain Rep. 2021;6:e884. doi: 10.1097/PR9.0000000000000884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PR9.0000000000000884</ArticleId><ArticleId IdType="pmc">PMC7850724</ArticleId><ArticleId IdType="pubmed">33537521</ArticleId></ArticleIdList></Reference><Reference><Citation>Bak&#x131;lan F., G&#xf6;kmen &#x130;.G., Ortanca B., U&#xe7;an A., Eker G&#xfc;ven&#xe7; &#x15e;., &#x15e;ahin Mutlu F., G&#xf6;kmen H.M., Ekim A. Musculoskeletal symptoms and related factors in postacute COVID-19 patients. Int. J. Clin. Pract. 2021;75:e14734. doi: 10.1111/ijcp.14734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14734</ArticleId><ArticleId IdType="pmc">PMC8420386</ArticleId><ArticleId IdType="pubmed">34387911</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaarslan F., Demircio&#x11f;lu G.F., Karde&#x15f; S. Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: Prospective follow-up by phone interviews. Rheumatol. Int. 2021;41:1263&#x2013;1271. doi: 10.1007/s00296-021-04882-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-021-04882-8</ArticleId><ArticleId IdType="pmc">PMC8114015</ArticleId><ArticleId IdType="pubmed">33978818</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares F.H.C., Kubota G.T., Fernandes A.M., Hojo B., Couras C., Costa B.V., Lapa J.D.D.S., Braga L.M., Almeida M.M., Cunha P.H.M.D., et al. &#x201c;Pain in the Pandemic Initiative Collaborators&#x201d;. Prevalence and characteristics of new-onset pain in COVID-19 survivours, a controlled study. Eur. J. Pain. 2021;25:1342&#x2013;1354. doi: 10.1002/ejp.1755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.1755</ArticleId><ArticleId IdType="pmc">PMC8013219</ArticleId><ArticleId IdType="pubmed">33619793</ArticleId></ArticleIdList></Reference><Reference><Citation>Bileviciute-Ljungar I., Norrefalk J.R., Borg K. Pain burden in post-COVID-19 syndrome following mild COVID-19 infection. J. Clin. Med. 2022;11:771. doi: 10.3390/jcm11030771.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11030771</ArticleId><ArticleId IdType="pmc">PMC8836662</ArticleId><ArticleId IdType="pubmed">35160223</ArticleId></ArticleIdList></Reference><Reference><Citation>Oguz-Akarsu E., Gullu G., Kilic E., Din&#xe7; Y., Ursavas A., Yilmaz E., Zarifoglu M., Karli N., Pandemic Study Team Insight into pain syndromes in acute phase of mild-to-moderate COVID-19: Frequency, clinical characteristics, and associated factors. Eur. J. Pain. 2021;26:492&#x2013;504. doi: 10.1002/ejp.1876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.1876</ArticleId><ArticleId IdType="pmc">PMC8653127</ArticleId><ArticleId IdType="pubmed">34622527</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrero-Montes M., Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Ferrer-Pargada D., Tello-Mena S., Cancela-Cilleruelo I., Rodr&#xed;guez-Jim&#xe9;nez J., Palacios-Ce&#xf1;a D., Par&#xe1;s-Bravo P. Prevalence of neuropathic component in post-COVID pain symptoms in previously hospitalized COVID-19 survivors. Int. J. Clin. Pract. 2022;2022:3532917. doi: 10.1155/2022/3532917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/3532917</ArticleId><ArticleId IdType="pmc">PMC9159239</ArticleId><ArticleId IdType="pubmed">35685491</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijs J., George S.Z., Clauw D.J., Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Kosek E., Ickmans K., Fern&#xe1;ndez-Carnero J., Polli A., Kapreli E., Huysmans E., et al. Central sensitisation in chronic pain conditions: Latest discoveries and their potential for precision medicine. Lancet Rheumatol. 2021;3:e383&#x2013;e392. doi: 10.1016/S2665-9913(21)00032-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(21)00032-1</ArticleId><ArticleId IdType="pubmed">38279393</ArticleId></ArticleIdList></Reference><Reference><Citation>Shraim M.A., Mass&#xe9;-Alarie H., Hodges P.W. Methods to discriminate between mechanism-based categories of pain experienced in the musculoskeletal system: A systematic review. Pain. 2021;162:1007&#x2013;1037. doi: 10.1097/j.pain.0000000000002113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002113</ArticleId><ArticleId IdType="pubmed">33136983</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzcharles M.A., Cohen S.P., Clauw D.J., Littlejohn G., Usui C., H&#xe4;user W. Nociplastic pain: Towards an understanding of prevalent pain conditions. Lancet. 2021;397:2098&#x2013;2110. doi: 10.1016/S0140-6736(21)00392-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00392-5</ArticleId><ArticleId IdType="pubmed">34062144</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett M.I., Smith B.H., Torrance N., Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: Validation for use in clinical and postal research. J. Pain. 2005;6:149&#x2013;158. doi: 10.1016/j.jpain.2004.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2004.11.007</ArticleId><ArticleId IdType="pubmed">15772908</ArticleId></ArticleIdList></Reference><Reference><Citation>Freynhagen R., Baron R., Gockel U., T&#xf6;lle T.R. painDETECT: A new screening questionnaire to identify neuropathic components in patients with back pain. Curr. Med. Res. Opin. 2006;22:1911&#x2013;1920. doi: 10.1185/030079906X132488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1185/030079906X132488</ArticleId><ArticleId IdType="pubmed">17022849</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauffin J., Hankama T., Kautiainen H., Hannonen P., Haanp&#xe4;&#xe4; M. Neuropathic pain and use of PainDETECT in patients with fibromyalgia: A cohort study. BMC Neurol. 2013;13:21. doi: 10.1186/1471-2377-13-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-13-21</ArticleId><ArticleId IdType="pmc">PMC3582578</ArticleId><ArticleId IdType="pubmed">23409793</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavrilova N., Soprun L., Lukashenko M., Ryabkova V., Fedotkina T.V., Churilov L.P., Shoenfeld Y. New clinical phenotype of the Post-COVID syndrome: Fibromyalgia and joint hypermobility condition. Pathophysiology. 2022;29:24&#x2013;29. doi: 10.3390/pathophysiology29010003.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathophysiology29010003</ArticleId><ArticleId IdType="pmc">PMC8954589</ArticleId><ArticleId IdType="pubmed">35366287</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xda;beda-D&#x2019;Ocasar E., Valera-Calero J.A., Gallego-Sendarrubias G.M., Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Arias-Bur&#xed;a J.L., Morales-Cabezas M., Arendt-Nielsen L., Cigar&#xe1;n-M&#xe9;ndez M. Association of neuropathic pain symptoms with sensitization related symptomatology in women with fibromyalgia. Biomedicines. 2022;10:612. doi: 10.3390/biomedicines10030612.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10030612</ArticleId><ArticleId IdType="pmc">PMC8945759</ArticleId><ArticleId IdType="pubmed">35327414</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer T.G., Neblett R., Cohen H., Howard K.J., Choi Y.H., Williams M.J., Perez Y., Gatchel R.J. The development and psychometric validation of the central sensitization inventory. Pain Pract. 2012;12:276&#x2013;285. doi: 10.1111/j.1533-2500.2011.00493.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1533-2500.2011.00493.x</ArticleId><ArticleId IdType="pmc">PMC3248986</ArticleId><ArticleId IdType="pubmed">21951710</ArticleId></ArticleIdList></Reference><Reference><Citation>Neblett R., Cohen H., Choi Y., Hartzell M.M., Williams M., Mayer T.G., Gatchel R.J. The Central Sensitization Inventory (CSI): Establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample. J. Pain. 2013;14:438&#x2013;445. doi: 10.1016/j.jpain.2012.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2012.11.012</ArticleId><ArticleId IdType="pmc">PMC3644381</ArticleId><ArticleId IdType="pubmed">23490634</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuesta-Vargas A.I., Neblett R., Chiarotto A., Kregel J., Nijs J., van Wilgen C.P., Pitance L., Knezevic A., Gatchel R.J., Mayer T.G., et al. Dimensionality and reliability of the Central Sensitization Inventory in a pooled multi-country sample. J. Pain. 2018;19:317&#x2013;329. doi: 10.1016/j.jpain.2017.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2017.11.006</ArticleId><ArticleId IdType="pubmed">29198933</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrmann-Lingen C., Buss U., Snaith R.P. Hospital Anxiety and Depression Scale&#x2013;Deutsche Version (HADS-D) Verlag Hans Huber; Bern, Switzerland: 2011.</Citation></Reference><Reference><Citation>Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193&#x2013;213. doi: 10.1016/0165-1781(89)90047-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-1781(89)90047-4</ArticleId><ArticleId IdType="pubmed">2748771</ArticleId></ArticleIdList></Reference><Reference><Citation>Woby S.R., Roach N.K., Urmston M., Watson P.J. Psychometric properties of the TSK-11: A shortened version of the Tampa Scale for Kinesiophobia. Pain. 2005;117:137&#x2013;144. doi: 10.1016/j.pain.2005.05.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pain.2005.05.029</ArticleId><ArticleId IdType="pubmed">16055269</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a Campayo J., Rodero B., Alda M., Sobradiel N., Montero J., Moreno S. Validation of the Spanish version of the Pain Catastrophizing Scale in fibromyalgia. Med. Clin. 2008;131:487&#x2013;492. doi: 10.1157/13127277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1157/13127277</ArticleId><ArticleId IdType="pubmed">19007576</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M., Gudex C., Lloyd A., Janssen M., Kind P., Parkin D., Bonsel G., Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Qual. Life Res. 2011;20:1727&#x2013;1736. doi: 10.1007/s11136-011-9903-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-011-9903-x</ArticleId><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hout B., Janssen M.F., Feng Y.J., Kohlmann T., Busschbach J., Golicki D., Lloyd A., Scalone L., Kind P., Pickard A.S. Interim scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15:708&#x2013;715. doi: 10.1016/j.jval.2012.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2012.02.008</ArticleId><ArticleId IdType="pubmed">22867780</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin P.C., Steyerberg E.W. The number of subjects per variable required in linear regression analyses. J. Clin. Epidemiol. 2015;68:627&#x2013;636. doi: 10.1016/j.jclinepi.2014.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2014.12.014</ArticleId><ArticleId IdType="pubmed">25704724</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins D.G., Quintana-Ascencio P.F. A solution to minimum sample size for regressions. PLoS ONE. 2020;15:e0229345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7034864</ArticleId><ArticleId IdType="pubmed">32084211</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhassira D., Lant&#xe9;ri-Minet M., Attal N., Laurent B., Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2008;136:380&#x2013;387. doi: 10.1016/j.pain.2007.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pain.2007.08.013</ArticleId><ArticleId IdType="pubmed">17888574</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreton B.J., Tew V., das Nair R., Wheeler M., Walsh D.A., Lincoln N.B. Pain phenotype in patients with knee osteoarthritis: Classification and measurement properties of painDETECT and self-report Leeds assessment of neuropathic symptoms and signs scale in a cross-sectional study. Arthritis Care Res. 2015;67:519&#x2013;528. doi: 10.1002/acr.22431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.22431</ArticleId><ArticleId IdType="pmc">PMC4407932</ArticleId><ArticleId IdType="pubmed">25155472</ArticleId></ArticleIdList></Reference><Reference><Citation>Felix E.R., Gater D.R., Jr. Interrelationship of neurogenic obesity and chronic neuropathic pain in persons with spinal cord injury. Top. Spinal Cord Inj. Rehabil. 2021;27:75&#x2013;83. doi: 10.46292/sci20-00062.</Citation><ArticleIdList><ArticleId IdType="doi">10.46292/sci20-00062</ArticleId><ArticleId IdType="pmc">PMC7983640</ArticleId><ArticleId IdType="pubmed">33814885</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattadori G., Di Marco S., Baravelli M., Picozzi A., Ambrosio G. Exercise training in post-COVID-19 patients: The need for a multifactorial protocol for a multifactorial pathophysiology. J. Clin. Med. 2022;11:2228. doi: 10.3390/jcm11082228.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11082228</ArticleId><ArticleId IdType="pmc">PMC9028177</ArticleId><ArticleId IdType="pubmed">35456321</ArticleId></ArticleIdList></Reference><Reference><Citation>Tampin B., Royle J., Bharat C., Trevenen M., Olsen L., Goucke R. Psychological factors can cause false pain classification on PainDETECT. Scand. J. Pain. 2019;19:501&#x2013;512. doi: 10.1515/sjpain-2018-0355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/sjpain-2018-0355</ArticleId><ArticleId IdType="pubmed">30901319</ArticleId></ArticleIdList></Reference><Reference><Citation>Finnerup N.B., Kuner R., Jensen T.S. Neuropathic pain: From Mechanisms to treatment. Physiol. Rev. 2021;101:259&#x2013;301. doi: 10.1152/physrev.00045.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00045.2019</ArticleId><ArticleId IdType="pubmed">32584191</ArticleId></ArticleIdList></Reference><Reference><Citation>van Wilgen C.P., Vuijk P.J., Kregel J., Voogt L., Meeus M., Descheemaeker F., Keizer D., Nijs J. Psychological distress and widespread pain contribute to the variance of the Central Sensitization Inventory: A cross-sectional study in patients with chronic pain. Pain Pract. 2018;18:239&#x2013;246. doi: 10.1111/papr.12600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/papr.12600</ArticleId><ArticleId IdType="pubmed">28449376</ArticleId></ArticleIdList></Reference><Reference><Citation>Kregel J., Schumacher C., Dolphens M., Malfliet A., Goubert D., Lenoir D., Cagnie B., Meeus M., Coppieters I. Convergent validity of the Dutch Central Sensitization Inventory: Associations with psychophysical pain measures, quality of life, disability, and pain cognitions in patients with chronic spinal pain. Pain Pract. 2018;18:777&#x2013;787. doi: 10.1111/papr.12672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/papr.12672</ArticleId><ArticleId IdType="pubmed">29222851</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams G.R., Gandhi W., Harrison R., van Reekum C.M., Gilron I., Salomons T.V. Do &#x201c;central sensitization&#x201d; questionnaires reflect measures of nociceptive sensitization or psychological constructs? Protocol for a systematic review. Pain Rep. 2021;6:e962. doi: 10.1097/PR9.0000000000000962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PR9.0000000000000962</ArticleId><ArticleId IdType="pmc">PMC8547908</ArticleId><ArticleId IdType="pubmed">34712886</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhassira D., Branders S., Attal N., Fernandes A.M., Demolle D., Barbour J., Ciampi de Andrade D., Pereira A. Stratification of patients based on the Neuropathic Pain Symptom Inventory: Development and validation of a new algorithm. Pain. 2021;162:1038&#x2013;1046. doi: 10.1097/j.pain.0000000000002130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002130</ArticleId><ArticleId IdType="pubmed">33136982</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>